Gene · 2057
Papers3,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation. | Cells | 2023 | 36980237 | PubTator, text mining | PubMed |
| A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia. | Biomedicines | 2023 | 36979925 | PubTator, text mining | PubMed |
| Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment. | Biology (Basel) | 2023 | 36979159 | PubTator, text mining | PubMed |
| Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities. | Nat Commun | 2023 | 36977662 | PubTator, text mining | PubMed |
| JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management. | Am J Hematol | 2023 | 36966432 | PubTator, text mining | PubMed |
| Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma. | Cancer Chemother Pharmacol | 2023 | 36961524 | PubTator, text mining | PubMed |
| Structural insights into the assembly of gp130 family cytokine signaling complexes. | Sci Adv | 2023 | 36930708 | PubTator, text mining | PubMed |
| The novel GATA1-interacting protein HES6 is an essential transcriptional cofactor for human erythropoiesis. | Nucleic Acids Res | 2023 | 36929421 | PubTator, text mining | PubMed |
| The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades. | J Hematol Oncol | 2023 | 36927623 | PubTator, text mining | PubMed |
| Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. | J Immunother Cancer | 2023 | 36927528 | PubTator, text mining | PubMed |
| Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. | J Transl Med | 2023 | 36922828 | PubTator, text mining | PubMed |
| Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease. | Front Med (Lausanne) | 2023 | 36910473 | PubTator, text mining | PubMed |
| Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients. | Ann Hematol | 2023 | 36907912 | PubTator, text mining | PubMed |
| Neuronal nitric oxide synthase is required for erythropoietin stimulated erythropoiesis in mice. | Front Cell Dev Biol | 2023 | 36895793 | PubTator, text mining | PubMed |
| Combinatorial protein dimerization enables precise multi-input synthetic computations. | Nat Chem Biol | 2023 | 36894721 | PubTator, text mining | PubMed |
| High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. | Am J Hematol | 2023 | 36880203 | PubTator, text mining | PubMed |
| EPO regulates neuronal differentiation of adult human neural-crest derived stem cells in a sex-specific manner. | BMC Neurosci | 2023 | 36879191 | PubTator, text mining | PubMed |
| Literature review on the interdisciplinary biomarkers of multi-target and multi-time herbal medicine therapy to modulate peripheral systems in cognitive impairment. | Front Neurosci | 2023 | 36875644 | PubTator, text mining | PubMed |
| Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia. | Blood Adv | 2023 | 36867579 | PubTator, text mining | PubMed |
| Live to die another day: novel insights may explain the pathophysiology behind smoker's paradox in SARS-CoV-2 infection. | Mol Cell Biochem | 2023 | 36867341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2057/papers?page=19